A noninferiority study was performed comparing low-dose and standard-dose prophylactic
platelet transfusions. A double-blind randomized controlled trial (RCT) was performed in 6 …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive SARS-…

Background and objectives: Intravenous Ig (IVIG) is used in renal transplantation for
desensitization and treatment of antibody-mediated rejection (AMR). The infusion of high-dose IVIG …

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) was once a highly fatal
disease with mortality reaching nearly 95 percent; however, application of therapeutic plasma …

Hypertriglyceridemia‐induced pancreatitis is a serious complication of familial dyslipidemias.
Hormonal influences during pregnancy can compromise otherwise controlled lipid levels in …

BACKGROUND: Conventional pretransfusion testing uses hemagglutination to ensure
donor‐recipient compatibility for ABO/D status and recipient alloantibodies. While screening large …

Background Primary graft dysfunction (PGD) is a major cause of early mortality following
heart transplant (HT). The International Society for Heart and Lung Transplantation (ISHLT) …

Background COVID‐19 convalescent plasma (CCP) is plasma collected from individuals
who have recovered from SARS‐CoV‐2 infection. The FDA Emergency Use Authorization …

This review examines the use of platelet-rich plasma (PRP) in the treatment of bone injuries
and to stimulate bone formation. Studies examining both in vivo bone healing and in vitro …

Background: Although there have been desensitization protocols used for ABO‐incompatible
(ABOi) renal transplants, there are a lack of studied protocols. Our center developed a …